A West Michigan maker of medical devices and equipment appointed a new vice president of investor relations.
Kalamazoo-based Stryker said Monday it appointed Preston Wells to the role, effective June 1. He will report to Glenn Boehnlein, Stryker’s CFO.
Wells is replacing Katherine Owen, who is retiring after 13 years in the position. In order to ensure a “smooth transition of her responsibilities,” Owen will transition to the role of adviser to the CEO through March 30, 2021.
“We would like to thank Katherine for the many significant contributions she has made to our company and for her demonstrated commitment to our success and growth,” said Kevin Lobo, chair and CEO of Stryker. “Katherine has strengthened our investor relations and business development capabilities, including the completion of many successful value-creating deals. I wish Katherine the very best in this new chapter of her life.”
Since 2016, Wells has served as vice president, financial planning and analysis, and Stryker said he “successfully transformed the company’s financial forecasting and budgeting processes.”
In his previous role, he worked closely with the company’s investor relations team to ensure a cohesive approach to investor reporting.
Wells has held leadership roles in finance for more than 20 years in various industries, including health care.
Previously, he supported Stryker’s spine business as senior director of finance, where he was responsible for all aspects of sales operations, sales finance, financial planning, and analysis and business unit finance.
Before that, Wells served as the CFO at Dialight Corporation, a $300 million manufacturer of LED lighting. He also held senior leadership positions at Johnson & Johnson’s U.S. consumer skincare business and U.K. reconstructive business.
Wells holds a bachelor’s degree in accounting from Bucknell University and a Master of Business Administration in supply chain management from Lehigh University.